Thomas Boehm

Dr.
Alumni

Max Planck Institute of Immunobiology and Epigenetics
Department of Developmental Immunology

Stübeweg 51
79108 Freiburg i. Brsg.

Current position

Scientific Member of the Max Planck Society, Director

Academic training

1975 – 1982 Study of Medicine in Frankfurt am Main

Scientific qualifications

1987 Habilitation in Biological Chemistry, University of Frankfurt (Mentor: Dr. L. Träger)
1982 Dissertation in Medicine, University of Frankfurt
(Supervisor: Dr. D. Drahovsky)

Postgraduate Positions

since 1998 Scientific Member of the Max Planck Society and Director at the Max Planck Institute of Immunobiology & Epigenetics, Freiburg
1995 – 1997 Professor of Experimental Therapy, German Cancer Research Center (DKFZ), Heidelberg
1992 – 1994 Professor of Molecular Medicine, University of Freiburg
1987 – 1991 Scientist, MRC Laboratory of Molecular Biology, Cambridge, UK
1982 – 1986 Research Fellow, Centers for Pediatrics and Biological Chemistry, University of Frankfurt

Miscellaneous (Honors, Awards)

2021 Heinrich Wieland Prize of Boehringer Ingelheim Foundation
2014 Ernst Jung Prize for Medicine
1997 Gottfried-Wilhelm-Leibniz Award of the German Science Council (DFG)
  • Member, Heidelberg Academy of Sciences
  • Member, German Academy of Sciences Leopoldina
  • Member, European Molecular Biology Organization

link to all publications from T. Boehm: Pubmed

Publications based on CRC1160 funding

Morimoto R, Swann J, Nusser A, Trancoso I, Schorpp M, Boehm T. 2021.  Evolution of thymopoietic microenvironments. Open Biol. 11(2):200383. doi: 10.1098/rsob.200383.

Swann JB, Nusser A, Morimoto R, Nagakubo D, Boehm T. 2020. Retracing the evolutionary emergence of thymopoiesis. Sci Adv. 6(48):eabd9585. doi: 10.1126/sciadv.abd9585.

Woopen C, Straub T, Schweier O, Aichele U, Düker K, Boehm T, Pircher H. 2018. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice. Eur J Immunol. 48(1):120-127.

Nagakubo D, Swann JB, Birmelin S, Boehm T. 2017. Autoimmunity associated with chemically induced thymic dysplasia. Int Immunol. 29(8):385-390.